Home
>
National Drug Code (NDC)
>
OSENI
OSENI - 64764-253-04 - (alogliptin and pioglitazone)
Drug Information of OSENI
| Product NDC: | 64764-253 |
| Proprietary Name: | OSENI |
| Non Proprietary Name: | alogliptin and pioglitazone |
| Active Ingredient(s): | 25; 30 mg/1; mg/1 & nbsp; alogliptin and pioglitazone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of OSENI
| Product NDC: | 64764-253 |
| Labeler Name: | Takeda Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022426 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130125 |
Package Information of OSENI
| Package NDC: | 64764-253-04 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (64764-253-04) |
NDC Information of OSENI
| NDC Code | 64764-253-04 |
| Proprietary Name | OSENI |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (64764-253-04) |
| Product NDC | 64764-253 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alogliptin and pioglitazone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130125 |
| Marketing Category Name | NDA |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 25; 30 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
